CBN
Cannabinol · CBN · Discovered 1896
Explore CBN (Cannabinol), the mildly sedating cannabinoid formed from aged THC. Learn about its sleep-promoting properties, mechanism of action, research evidence, and how it compares to other cannabinoids.
Psychoactive
Yes
Discovered
1896
Effects
8 documented
Benefits
4 studied
Overview
Cannabinol (CBN) was the first cannabinoid to be isolated from cannabis, identified by British chemist Robert Sidney Cahn in 1896 and structurally elucidated in 1940. CBN is not directly synthesized by the cannabis plant; instead, it is a degradation product of THC. When THC is exposed to heat, light, and oxygen over time, it oxidizes and converts to CBN. This is why aged or improperly stored cannabis tends to have higher CBN content and is often associated with a more sedating, sleepy effect compared to fresh material.
CBN has gained significant commercial attention as a sleep aid, marketed heavily in the cannabis wellness industry as a natural alternative to pharmaceutical sleep medications. However, the scientific evidence for CBN's sedative properties in humans is surprisingly limited, with much of its reputation stemming from anecdotal reports and the association between aged cannabis and sleepiness. Some researchers hypothesize that the sedating effect of old cannabis may be due to changes in the overall terpene and cannabinoid profile rather than CBN alone.
Despite the limited evidence for its sleep claims, CBN has demonstrated other promising therapeutic properties in preclinical research, including anti-inflammatory, antibacterial, appetite-stimulating, and neuroprotective effects. CBN is mildly psychoactive, with approximately one-quarter the potency of THC at the CB1 receptor, but at the concentrations typically found in products (5-10mg per dose), psychoactive effects are minimal.
Mechanism of Action
CBN binds to CB1 receptors with approximately 10-25% the affinity of THC, making it mildly psychoactive but significantly less intoxicating. It shows higher affinity for CB2 receptors, suggesting a role in immune modulation and anti-inflammatory activity. CBN also interacts with TRPV2 channels, which are involved in pain sensation, immune function, and bone density regulation. Its interaction with TRPV2 receptors is particularly notable because it may explain CBN's reported effects on pain and inflammation through non-cannabinoid receptor mechanisms. CBN has demonstrated activity at adenosine A2A receptors, which are involved in sleep regulation and could partially explain its sedative reputation. It also inhibits cyclooxygenase enzymes (COX-1 and COX-2), providing anti-inflammatory effects similar to non-steroidal anti-inflammatory drugs.
Therapeutic Effects
Potential Benefits
Insomnia and Sleep Disorders
Limited direct human evidence. A single 1975 study found CBN enhanced the sedating effects of THC in five male subjects. Its reputation as a sleep aid is largely anecdotal, though its TRPV2 and adenosine receptor activity provide plausible mechanisms. More clinical trials are needed.
Pain and Inflammation
Preclinical evidence. CBN has shown analgesic effects in animal models, particularly for conditions involving TRPV2 receptor pathways. A 2019 study found CBN reduced myofascial pain in a rat model, and it demonstrates COX enzyme inhibition similar to NSAIDs.
Bacterial Infections
Laboratory evidence. Like CBG, CBN has shown potent antibacterial activity against MRSA strains in vitro. A 2008 study in the Journal of Natural Products found CBN among the cannabinoids most effective against drug-resistant Staphylococcus aureus.
Bone Healing
Preclinical evidence. Research suggests CBN may stimulate the recruitment of mesenchymal stem cells from bone marrow, potentially promoting bone growth and healing. This effect appears to be mediated through CB2 receptor activation.
Side Effects & Risks
- ⚠Drowsiness and sedation (desired when used as sleep aid)
- ⚠Mild psychoactive effects at higher doses
- ⚠Dizziness
- ⚠Grogginess upon waking if dose is too high
- ⚠Limited safety data from controlled human studies
- ⚠Potential drug interactions not well characterized
Concentration & Sources
Typical Concentration
Less than 1% in fresh cannabis flower; up to 3-5% in aged cannabis; 2.5-10mg per dose in commercial sleep products
Found In
Aged or oxidized cannabis flower, cannabis products exposed to light and air over time, and commercial CBN sleep products including tinctures, capsules, and gummies. Often combined with CBD and melatonin in sleep formulations.
Legal Status
Legal status varies. Not specifically scheduled federally in the US when derived from hemp, though its relationship to THC creates regulatory ambiguity. Some states classify CBN alongside THC. Legal in most countries when present in trace amounts.
Research Summary
CBN holds the distinction of being the first cannabinoid ever isolated, yet it remains understudied compared to THC and CBD. The strongest marketing claim — that CBN is a powerful sedative — rests on thin scientific evidence, primarily a single 1975 human study with only five participants. However, recent preclinical research has reinvigorated interest in CBN for other applications. Studies have demonstrated antibacterial activity against MRSA, analgesic effects through TRPV2 receptor activation, potential bone-healing properties via stem cell recruitment, and appetite stimulation in animal models. A 2022 study by Corroon published in Cannabis and Cannabinoid Research surveyed CBN product users and found that 60% reported improved sleep quality, though placebo effects cannot be excluded without controlled trials. Several clinical trials investigating CBN for sleep and pain are now underway, which should provide more definitive evidence within the next few years.
Related Cannabinoids
CBN FAQ
Is CBN good for sleep?
CBN is widely marketed as a sleep aid, but the scientific evidence is limited. Its sedative reputation comes largely from anecdotal reports associating aged cannabis with sleepier effects. One small 1975 study found CBN enhanced THC's sedating effects, but no large clinical trials have confirmed CBN as a standalone sleep aid. Consumer surveys show subjective sleep improvement, but controlled trials are needed. Many CBN sleep products combine it with CBD, melatonin, and sedating terpenes, making it difficult to attribute benefits to CBN alone.
Does CBN get you high?
CBN is mildly psychoactive, with about 10-25% of THC's potency at CB1 receptors. At the doses typically found in commercial products (2.5-10mg), most people do not experience noticeable psychoactive effects. However, higher doses may produce mild euphoria and sedation. Some users report subtle mood changes and relaxation similar to a very mild THC effect.
How is CBN different from CBD?
CBN and CBD differ in their origin, receptor activity, and effects. CBN is a degradation product of THC and has mild psychoactive properties, while CBD is non-psychoactive. CBN has higher affinity for CB1 and CB2 receptors compared to CBD. CBD acts primarily through serotonin, GABA, and TRPV1 receptors. CBN is primarily marketed for sleep, while CBD has broader applications for anxiety, inflammation, and seizures. CBD has far more clinical evidence supporting its use.
How do you increase CBN in cannabis?
CBN forms naturally when THC degrades through exposure to oxygen, UV light, and heat over time. To increase CBN content, cannabis can be deliberately aged in a warm environment with some air exposure for several weeks. Extended curing, exposure to UV light, and storing cannabis in non-airtight containers will accelerate THC-to-CBN conversion. Commercially, CBN is produced through controlled oxidation of THC or direct chemical synthesis.
Continue Exploring
Disclaimer: Cannabinoid information is provided for educational purposes only. Medical benefits are based on published research and are not intended as medical advice. Individual responses to cannabinoids vary. Always consult a healthcare professional before using cannabis for medical purposes. Legal status information is current as of publication but may change — verify your local laws.